Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- About 2× their largest earlier purchase here.
- 3 different insiders bought in the last 90 days.
- Similar past buys beat the S&P 500 52% of the time (221 cases), above the 46% for all buys.
Reasons for caution
- Their past buys: only 6 of 15 beat the S&P 500.
What happened after this filing
Insider Twins: past buys with the same traits
3+ insiders buying · incl. CEO or CFO · $250K–$1M · stock down 20%+ in 3 months
RHP Mar 18, 2020 +155.5% vs S&PMARA Dec 30, 2022 +123.0% vs S&PLGVN Apr 12, 2024 +120.9% vs S&PASTI Oct 2, 2023 -62.0% vs S&PINTZ Nov 13, 2023 -61.9% vs S&PSMHI Mar 19, 2020 -61.0% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Jon E. Bortz (a director) bought $680K of HPP at about $9.07 between Nov 9, 2026 and Nov 11, 2026, reported to the SEC on Nov 12, 2026. Buys like this beat the S&P 500 52% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the HPP alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.